---
title: "Nutriband (NTRB) news: delisting, going concern and offering"
url: "https://aibio.space/companies/nutriband/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "NTRB delisting, going concern, offering, convertible notes and lawsuit news: Nasdaq files removal notice as Nutriband public warrants expire. Nutriband Inc."
---

NTRB Nutriband Inc. NASDAQ · United States

# Nutriband (NTRB) news NTRB delisting, going concern and offering news

Listings · 2026-09-30

## [Nasdaq files removal notice as Nutriband public warrants expire](https://aibio.space/news/nasdaq-files-removal-notice-nutriband-public-warrants-expire/)

Nutriband's public warrants expired on September 30 without extension or repricing. Nasdaq filed a Form 25 to remove them. The company said its common stock is not affected.

## Latest Nutriband news

1. 2026-09-04 Financings [Nutriband reports $3.42 million cash, says operations will fund the next year](https://aibio.space/news/nutriband-reports-3-42-million-cash-says-operations-will-fund-next/) Nutriband says its operations will fund the next year and that going-concern doubt is gone, but revenue and spending both fell in the quarter and the company still burned cash.
2. 2026-09-04 Legal [Nutriband says lawsuit over ended offering engagement remains in discovery](https://aibio.space/news/nutriband-says-lawsuit-ended-offering-engagement-remains-discovery/) Joseph Gunnar and Lucosky Brookman sued Nutriband, CEO Gareth Sheridan, President Serguei Melnik, Vitalie Botgros, TII Jet Services and Wolf Blitz in 2023 over a terminated offering engagement. Nutriband denies the claims and has counterclaimed.
3. 2026-06-01 Debt Financing [Nutriband extends $5 million related-party credit line tied to Kindeva work](https://aibio.space/news/nutriband-extends-5-million-related-party-credit-line-tied-kindeva/) Nutriband amended its $5 million credit line with TII Jet Services, a lender in Portugal. Advances carry 7% interest and may be used only for work with Kindeva toward the fentanyl NDA.
4. 2026-02-13 Mergers [Nutriband terminates planned $5 million sale of Pocono unit](https://aibio.space/news/nutriband-terminates-planned-5-million-sale-pocono-unit/) Nutriband said its board ended the deal after the buyer missed the December 31 closing and stopped paying late fees. The annual report puts the price at $5 million, and only $30,000 in late fees was received.
5. 2025-09-03 Financings [Nutriband reports $5.31 million from warrant exercises in six months to July 31](https://aibio.space/news/nutriband-reports-5-31-million-warrant-exercises-six-months-july-31/) Private investors exercised warrants for 778,041 shares and public holders for 47,076 shares. Employee options added $44,206.
6. 2025-08-05 Financings [Nutriband distributes 3 million Series A preferred shares convertible on FDA approval](https://aibio.space/news/nutriband-distributes-3-million-series-preferred-shares-convertible/) Holders got one non-voting preferred share for every four common shares. The shares convert one-for-one only after FDA approval of an AVERSA-based product.

## Nutriband at a glance

- **Ticker**: NTRB

- **Listing**: NASDAQ

- **Country**: United States

- **Cash, Jul 31, 2026**: $3.4 million

### Related companies

- [Dyadic International](https://aibio.space/companies/dyadic-international/) NASDAQ: DYAI
- [Polaryx Therapeutics](https://aibio.space/companies/polaryx-therapeutics/) NASDAQ: PLYX
- [Endovia Health Sciences](https://aibio.space/companies/endovia-health-sciences/) AMEX: EDVA
- [Alpha Cognition](https://aibio.space/companies/alpha-cognition/) NASDAQ: ACOG
- [BioRestorative Therapies](https://aibio.space/companies/biorestorative-therapies/) NASDAQ: BRTX
- [Apollomics](https://aibio.space/companies/apollomics/) NASDAQ: APLM
- [Bone Biologics](https://aibio.space/companies/bone-biologics/) NASDAQ: BBLG
- [Celularity](https://aibio.space/companies/celularity/) NASDAQ: CELU

### Also on NASDAQ

- [Journey Medical](https://aibio.space/companies/journey-medical/) DERM
- [MBX Biosciences](https://aibio.space/companies/mbx-biosciences/) MBX
- [BioNexus Gene Lab](https://aibio.space/companies/bionexus-gene-lab/) BGLC
- [Edesa Biotech](https://aibio.space/companies/edesa-biotech/) EDSA
- [Retension Pharmaceuticals](https://aibio.space/companies/retension-pharmaceuticals/) RTSN
- [Sanara MedTech](https://aibio.space/companies/sanara-medtech/) SMTI

## Nutriband annual financials

| Line | FY ended Jan 31, 2026 | FY ended Jan 31, 2025 |
|---|---|---|
| Revenue | [$2.0 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/) | [$2.1 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/) |
| Research and development | [$1.9 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/) | [$3.1 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/) |
| Net income (loss) | [-$8.2 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/) | [-$10.5 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/) |
| Cash from operations | [-$5.1 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/) | [-$4.6 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/) |
| Cash and equivalents | [$4.6 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026097701/) | [$4.3 million](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/) |

Latest balance sheet, Jul 31, 2026 (10-Q): cash and equivalents $3.4 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Nutriband

Was Nutriband delisted?

Our latest story on this, dated Sep 30, 2026: "Nasdaq files removal notice as Nutriband public warrants expire". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/nasdaq-files-removal-notice-nutriband-public-warrants-expire/).

Has Nutriband issued a going-concern warning?

Our latest story on this, dated Sep 4, 2026: "Nutriband reports $3.42 million cash, says operations will fund the next year". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/nutriband-reports-3-42-million-cash-says-operations-will-fund-next/).

Has Nutriband raised money recently?

Our latest story on this, dated Sep 4, 2026: "Nutriband says lawsuit over ended offering engagement remains in discovery". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/nutriband-says-lawsuit-ended-offering-engagement-remains-discovery/).

Has Nutriband sold convertible notes?

Our latest story on this, dated Aug 5, 2025: "Nutriband distributes 3 million Series A preferred shares convertible on FDA approval". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/nutriband-distributes-3-million-series-preferred-shares-convertible/).

Is Nutriband involved in a lawsuit?

Our latest story on this, dated Sep 4, 2026: "Nutriband says lawsuit over ended offering engagement remains in discovery". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/nutriband-says-lawsuit-ended-offering-engagement-remains-discovery/).

What is the ticker symbol of Nutriband?

Nutriband Inc. trades under the ticker NTRB on NASDAQ.

Where is Nutriband listed?

Nutriband Inc. is listed on NASDAQ.

What is the SEC CIK of Nutriband?

The SEC Central Index Key (CIK) for Nutriband Inc. is 1676047. Its filings are on SEC EDGAR.

How many shares does Nutriband have outstanding?

12,155,683 shares as of 2026-09-04, per the cover page of its 10-Q filed 2026-09-04.

Which country or territory is Nutriband listed under?

Our directory records Nutriband Inc. under United States.

What does Nutriband do?

Our directory classifies Nutriband Inc. as: Biopharma / pharmaceuticals. This is a directory classification, not a description of the pipeline.

What is the ISIN of Nutriband?

The ISIN recorded for Nutriband Inc. is US67092M2089.

Does aibio.space cover Nutriband?

aibio.space lists Nutriband Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Where is Nutriband incorporated?

SEC records list its state or country of incorporation as NV.

What was Nutriband's revenue last year?

$2.0 million for the fiscal year ended Jan 31, 2026, as reported to the SEC.

## Investor discussion: Nutriband

Members talk about Nutriband (NTRB). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Nutriband, newest first. Each line links the filing it comes from.

1. 2026-09-30 Delisting Nasdaq filed a removal notice for the warrant class, not the common shares. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000135445726000928/xslF25X02/primary_doc.xml)
2. 2026-09-04 Going concern The interim report said management believed substantial doubt was alleviated because it projected that operations would fund the company for one year. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026097701/ea0303675-10q_nutriband.htm)
3. 2026-06-01 Financing Nutriband reported a three-year amendment to its credit facility, with use and draw restrictions. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026070378/ea0295410-8k_nutriband.htm)
4. 2026-04-29 Going concern Management said substantial doubt was alleviated in the annual report. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/ea0287168-10k_nutriband.htm)
5. 2026-02-13 Merger Nutriband reported termination of its planned Pocono disposal, attributing the failed close and late-fee shortfall to the purchaser. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/ea0287168-10k_nutriband.htm)
6. 2026-01-24 Leadership The board appointed two additional directors after the annual meeting. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026011304/ea0275277-8k_nutriband.htm)
7. 2025-09-03 Financing Nutriband reported proceeds from public and private warrant exercises over the preceding half-year. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390025083882/ea0255859-8k_nutriband.htm)
8. 2025-08-07 Financings Reported an unregistered sale of its securities. SEC Form 8-K (Items 3.02,5.03,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390025073116/ea0252295-8k_nutriband.htm)
9. 2025-07-08 Financings Filed a final prospectus for a securities offering. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390025061851/ea0248285-424b4_nutri.htm)

## Investor questions about Nutriband

### Did the identified Form 25 delist NTRB common shares?

No. It identifies warrants as the security class. The company expressly said the warrant expiration did not affect its common shares. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000135445726000928/xslF25X02/primary_doc.xml)

### When did the public warrants expire?

The company announced expiration at 17:00 Eastern Time on 2026-09-30 under their original terms. Exact exercises immediately before expiration remain unverified. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026102721/ea0306424-8k_nutriband.htm)

### How much cash was reported?

The latest quarterly balance sheet reports $3,421,615 at 2026-07-31. It is not a current daily cash figure. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026097701/ea0303675-10q_nutriband.htm)

### What runway did management state?

Management projected operating funding for one year from interim-statement filing. This is not a guarantee or a precise cash-exhaustion date. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026097701/ea0303675-10q_nutriband.htm)

### Did management leave substantial doubt unresolved?

The latest interim report says management believed substantial doubt was alleviated by its assessment. Going-concern discussion is still present. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026097701/ea0303675-10q_nutriband.htm)

### Was the credit ceiling already available as unrestricted cash?

No. The note has a ceiling, draw conditions and use restrictions. The quarterly report states the related-party line balance was zero at its reporting dates. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026070378/ea029541001ex10-30b.htm)

### What is the verified credit maturity?

The date is unreconciled: the filed note and latest quarterly narrative give different maturity dates. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026070378/ea029541001ex10-30b.htm)

### Was the planned Pocono disposal completed?

Nutriband reported terminating the agreement. It attributed the decision to the purchaser not completing the transaction and not continuing late-fee payments. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/ea0287168-10k_nutriband.htm)

### Did the preferred dividend itself raise cash?

It was a stock distribution to existing holders, with conversion subject to specified conditions. It was not described as a subscription payment to the company. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390025073116/ea0252295-8k_nutriband.htm)

### Who audits Nutriband?

The annual audit is signed by Sadler, Gibb & Associates, LLC. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/ea0287168-10k_nutriband.htm)

### What litigation is disclosed?

The quarterly report describes an offering-engagement dispute and denied counterclaims. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026097701/ea0303675-10q_nutriband.htm)

### Are all warrant series covered by the public expiration?

No. The quarterly warrant table includes several series; the public notice concerns the NTRBW class. No current total is derived by mechanically subtracting its historical count. [Source](https://www.sec.gov/Archives/edgar/data/1676047/000121390026102721/ea0306424-8k_nutriband.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:NTRB on TradingView](https://www.tradingview.com/symbols/NASDAQ-NTRB/).

## SEC filings and registration

- **SEC name**: NutriBand Inc.

- **CIK**: 1676047

- **Industry (SIC)**: Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

- **US tickers**: NTRB (Nasdaq), NTRBW (Nasdaq)

- **State or country of incorporation**: NV

- **Fiscal year ends**: January 31

- **Filer category**: <br>Emerging growth company

- **Business address**: 121 S. ORANGE AVE., ORLANDO, FL, 32801

- **Phone**: 407 377-6695

- **Shares outstanding**: 12,155,683 as of 2026-09-04 (10-Q filed 2026-09-04)

### Recent filings (8-K and 6-K are the company's own announcements)

- [8-K](https://www.sec.gov/Archives/edgar/data/1676047/000121390026102721/ea0306424-8k_nutriband.htm) filed 2026-09-23
- [10-Q](https://www.sec.gov/Archives/edgar/data/1676047/000121390026097701/ea0303675-10q_nutriband.htm) filed 2026-09-04
- [8-K](https://www.sec.gov/Archives/edgar/data/1676047/000121390026070378/ea0295410-8k_nutriband.htm) filed 2026-06-22
- [10-Q](https://www.sec.gov/Archives/edgar/data/1676047/000121390026067840/ea0294013-10q_nutriband.htm) filed 2026-06-11
- [10-K](https://www.sec.gov/Archives/edgar/data/1676047/000121390026049399/ea0287168-10k_nutriband.htm) filed 2026-04-29
- [8-K](https://www.sec.gov/Archives/edgar/data/1676047/000121390026041006/ea0285330-8k_nutriband.htm) filed 2026-04-07
- [8-K](https://www.sec.gov/Archives/edgar/data/1676047/000121390026016550/ea0277156-8k_nutriband.htm) filed 2026-02-13
- [8-K](https://www.sec.gov/Archives/edgar/data/1676047/000121390026011304/ea0275277-8k_nutriband.htm) filed 2026-02-03

Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001676047), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.

## Listing details

Nutriband Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NTRB, recorded under United States. The directory classifies it as Biopharma / pharmaceuticals. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Nutriband Inc.

- **Ticker**: NTRB

- **Listing**: NASDAQ

- **Country or territory**: United States

- **Business scope**: Biopharma / pharmaceuticals

- **ISIN**: US67092M2089

- **Last quote in directory**: 2026-10-21

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-NTRB/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/nutriband/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Nutriband (NTRB) news: delisting, going concern and offering", 2026-10-31, https://aibio.space/companies/nutriband/